Ali Aşan
Impact in
-
- COVID-19 Clinical Research Studies
- Infection Control in Healthcare
Papers in
- Epidemiology 16
- Hepatitis B Virus Studies 11
- Infective Endocarditis Diagnosis and Management 3
-
- SARS-CoV-2 and COVID-19 Research 5
- COVID-19 Clinical Research Studies 3
- Antimicrobial Resistance in Staphylococcus 3
- Co-authors
- Suzan Saçar (11 shared papers)İlknur Kaleli̇ (6 shared papers)Mustafa Saçar (6 shared papers)Nural Cevahir (5 shared papers)Koray Tekin (2 shared papers)Hüseyin Turgut (8 shared papers)Nermin Kelebek Girgin (1 shared paper)Ahmet Baltalarlı (4 shared papers)
- Journals
- Human Vaccines & Immunotherapeutics (1 paper)International Journal of Infectious Diseases (1 paper)Journal of Medical Virology (1 paper)American Journal of Infection Control (1 paper)Open Forum Infectious Diseases (1 paper)
- Partner nations
- TürkiyeUnited StatesCambodia
In The Last Decade
Ali Aşan
26 papers receiving 243 citations
Peers
Comparison fields: 5 of 74
- Infectious Diseases 104
- Applied Microbiology and Biotechnology 11
- Occupational Therapy 21
- Hepatology 38
- Critical Care and Intensive Care Medicine 19
Countries citing papers authored by Ali Aşan
This map shows the geographic impact of Ali Aşan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Aşan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Aşan more than expected).
Fields of papers citing papers by Ali Aşan
This network shows the impact of papers produced by Ali Aşan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Aşan. The network helps show where Ali Aşan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Aşan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 39 | |
| 2 | 2020 | 32 | |
| 3 | 2017 | 30 | |
| 4 | 2005 | 24 | |
| 5 | 2020 | 22 | |
| 6 | 2022 | 12 | |
| 7 | 2008 | 10 | |
| 8 | 2017 | 9 | |
| 9 | Comparison of antimicrobial agents as therapy for experimental endocarditis: caused by methicillin-resistant Staphylococcus aureus. | 2010 | 8 |
| 10 | 2008 | 8 | |
| 11 | 2022 | 7 | |
| 12 | 2007 | 7 | |
| 13 | 2014 | 7 | |
| 14 | 2007 | 6 | |
| 15 | 2013 | 5 | |
| 16 | 2016 | 5 | |
| 17 | 2020 | 4 | |
| 18 | 2023 | 4 | |
| 19 | Pamukkale Üniversitesi Tıp Fakültesi Hastanesinde antibiyotik kullanımına ilişkin nokta prevalans çalışması | 2006 | 3 |
| 20 | 2022 | 3 |
About Ali Aşan
Ali Aşan is a scholar working on Epidemiology, Infectious Diseases, Hepatology, Surgery and Immunology, having authored 35 papers that have together received 256 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (11 papers), Hepatitis C virus research (11 papers), Hepatitis Viruses Studies and Epidemiology (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Infective Endocarditis Diagnosis and Management (3 papers), COVID-19 Clinical Research Studies (3 papers), Immune Cell Function and Interaction (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). The work is most often cited by research in Infectious Diseases (104 citations), Applied Microbiology and Biotechnology (11 citations), Occupational Therapy (21 citations), Hepatology (38 citations) and Critical Care and Intensive Care Medicine (19 citations). Ali Aşan has collaborated with scholars based in Türkiye, United States and Cambodia. Frequent co-authors include Suzan Saçar, İlknur Kaleli̇, Mustafa Saçar, Nural Cevahir, Koray Tekin, Hüseyin Turgut, Nermin Kelebek Girgin, Ahmet Baltalarlı, Kağan Huysal and Alper Şener. Their work appears in journals such as Human Vaccines & Immunotherapeutics, International Journal of Infectious Diseases, Journal of Medical Virology, American Journal of Infection Control and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.